Ok that clears that up. Thank you. Still pondering the reason for the comparison group to cohort 2 being further along the disease progression spectrum than cohort 2. The one death as we know was a bull bar onset victim and seemed to occur around 11 moths from diagnosis. The survival curve of the PRO-ACT database really plummets from about 13 months. The survival rate from the OLE from this point will be telling.
Ann: OLE Study update reveals impressive Survival Data, page-120
-
- There are more pages in this discussion • 129 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $99.71M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.0¢ | $66.86K | 327.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27750 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 84999 | 3 |
View Market Depth
| Last trade - 14.42pm 27/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |